In preclinical experiments, the combination of transcutaneous, low-frequency ultrasound and thrombolytic therapy has shown improved patency rates over thrombolytics alone. A total of 25 patients with myocardial infarction were treated with a thrombolytic agent and adjunctive transcutaneous ultrasound. No unanticipated major adverse events were observed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0002-9149(03)00666-0 | DOI Listing |
Publication Analysis
Top Keywords
myocardial infarction
8
transcutaneous ultrasound-facilitated
4
ultrasound-facilitated coronary
4
coronary thrombolysis
4
thrombolysis acute
4
acute myocardial
4
infarction preclinical
4
preclinical experiments
4
experiments combination
4
combination transcutaneous
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!